Antibiotic linked with rare but deadly heart risk

An antibiotic widely used for bronchitis and other common infections seems to increase chances for sudden deadly heart problems, a rare but surprising risk found in a 14-year study.

Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled Therapeutic Reduced Airway Inflammation

Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced the results of a clinical study showing that an iCALM™ attenuated allergen-induced bronchitis in susceptible asthmatic patients.

Former Khmer Rouge Minister for Foreign Affairs Ieng Sary

has been undergoing emergency treatment for bronchitis since Thursday, according to a medical report read aloud at the Khmer Rouge tribunal yesterday.

Antibiotic linked with rare heart-related deaths in study of Medicaid patients

CHICAGO - An antibiotic widely used for bronchitis and other common infections seems to increase chances for sudden deadly heart problems, a rare but surprising risk found in a 14-year study.

Zithromax antibiotics tied to rare heart risks

Study suggests there would be 47 extra heart-related deaths per 1 million courses of treatment with Zithromax